alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › anti

anti

7 studies tagged anti, dated 2005-08-01 to 2018-05-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Association of Tea Consumption with Risk of Alzheimer's Disease and Anti-Beta-Amyloid Effects of Tea 2018-05-22
  2. Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research? 2017-01-26
  3. Anti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials 2008-12-01

Studies

7 studies carry this tag.

Date range

2005 to 2018

Top journals

  • Autoimmunity reviews 1
  • Experimental neurology 1
  • Journal of Alzheimer's disease : JAD 1
  • Journal of molecular biology 1
  • Journal of negative results in biomedicine 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Association of Tea Consumption with Risk of Alzheimer's Disease and Anti-Beta-Amyloid Effects of Tea

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Nutrients 2018-05-22 Treatments

    Neurodegenerative disease Alzheimer's disease (AD) is attracting growing concern because of an increasing patient population among the elderly.

  2. Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of negative results in biomedicine 2017-01-26 Treatments

    We find that the concept of Aβ lacks clarity as a specific entity.

  3. Anti-amyloid-beta immunotherapy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2008-12-01 Treatments

    Therapeutic approaches to the treatment of Alzheimer's disease are focused primarily on the amyloid-beta peptide which aggregates to form amyloid deposits in the brain.

  4. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of molecular biology 2008-01-30 Treatments

    Alzheimer's disease (AD) is the most common form of dementia.

  5. Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Vision research 2007-09-20 Treatments

    Age-related macular degeneration (AMD) is a late-onset, neurodegenerative retinal disease that shares several clinical and pathological features with Alzheimer's disease (AD) including extracellular deposits containing amyloid-beta (Abeta) peptides.

  6. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Experimental neurology 2007-05-22 Treatments

    Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients.

  7. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Autoimmunity reviews 2005-08-01 Treatments

    The deposition of amyloid beta (Abeta) protein is a key pathological feature in Alzheimer's disease (AD).

All topic tags with their study counts